Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe/simvastatin versus atorvastatin 20 mg in patients with type 2 diabetes and hypercholesterolemia
2004-003000-37Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of ezetimibe and atorvastatin in hypercholesterolemia (3 arms), sponsored by Merck & Co. Primary endpoint: LDL-C lowering. Started Dec 2004; status: completed.
02
Drugs
ezetimibeatorvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on 2004-003000-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003000-37.